Source · Select Committees · Health and Social Care Committee
Recommendation 16
16
Paragraph: 96
As part of its new cancer plan, the Government should include a plan for how...
Recommendation
As part of its new cancer plan, the Government should include a plan for how to better align the technology appraisals carried out by NICE with the regulatory process applied by the MHRA, in order to reduce the delay between a drug being approved by the MHRA and recommended for use in the NHS by NICE. The Government should also review the uptake of NICE-approved treatments in the NHS and ensure that its new cancer plan includes measures to improve the pace of adoption of newly-approved treatments in the NHS on a fair and equitable basis.
Paragraph Reference:
96
Government Response
A response document is linked to this report, dated 13 June 2022. Response attribution to this recommendation has not been verified. Read the response document ↗